Which antihistamine is used in motion sickness?
Pirenzepine acts on which receptor?
Which of the following statements regarding adrenergic receptors is NOT true?
Which of the following antiglaucoma drugs can cause heterochromia iridis?
The beneficial effect of neostigmine in the treatment of Myasthenia gravis is due to which action?
Which of the following is NOT a cholinergic action?
Which of the following receptors does not require the action of adrenaline for the treatment of anaphylactic shock?
All of the following are actions of muscarinic antagonists except?
Which of the following sympathomimetic amines has agonistic action on a1, a2, b1, and b3 adrenoceptors, but not on b2 receptors?
What is the antidote for datura poisoning?
Explanation: ### Explanation **1. Why Diphenhydramine is Correct:** Motion sickness occurs due to overstimulation of the vestibular apparatus in the inner ear. The vestibular nuclei send signals to the vomiting center via pathways rich in **H1 (Histaminergic)** and **M1 (Muscarinic)** receptors. [1] **Diphenhydramine** is a **first-generation H1 antihistamine**. Unlike newer drugs, first-generation antihistamines are highly lipid-soluble and cross the **blood-brain barrier (BBB)**. [1], [3] They possess significant **anticholinergic (antimuscarinic) properties**, which are essential for suppressing the vestibular-cerebellar pathways. [1] This dual action (central H1 blockade + anticholinergic effect) makes it effective for preventing and treating motion sickness. **2. Why the Other Options are Incorrect:** * **Cetirizine (A) and Fexofenadine (D):** These are **second-generation antihistamines**. They are designed to be non-sedating because they have poor CNS penetration (do not cross the BBB) and lack significant anticholinergic activity. [1] Therefore, they are ineffective for motion sickness. * **Meclizine (B):** While Meclizine is indeed used for motion sickness (especially for its long duration of action), in the context of standard medical examinations, **Diphenhydramine** (or Dimenhydrinate) is often the classic prototype cited for acute management. [1], [2] *Note: If this were a "multiple correct" scenario, Meclizine would also be right, but Diphenhydramine remains a primary pharmacological representative of the class.* **3. NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC) for Motion Sickness (Prophylaxis):** Hyoscine (Scopolamine) administered via a transdermal patch behind the ear. [2] * **Timing:** Antihistamines/Anticholinergics must be taken **30–60 minutes before** the journey to be effective. [1], [2] * **Common Side Effects:** Sedation (most common), dry mouth, blurred vision, and urinary retention (due to anticholinergic effects). [1], [3] * **Dimenhydrinate:** This is simply the chlorotheophylline salt of diphenhydramine, commonly used for the same indication. [1]
Explanation: **Explanation:** **Pirenzepine** is a selective **Muscarinic (M1) receptor antagonist**. It belongs to the class of anticholinergic drugs. 1. **Why Muscarinic is correct:** Muscarinic receptors (M1–M5) are G-protein coupled receptors that mediate the parasympathetic effects of acetylcholine. Pirenzepine specifically targets **M1 receptors** located on gastric parietal cells and autonomic ganglia. By blocking these receptors, it reduces gastric acid secretion, which is why it was historically used in the treatment of peptic ulcers. 2. **Why other options are incorrect:** * **Nicotinic:** These are ligand-gated ion channels found at the neuromuscular junction (Nm) and autonomic ganglia (Nn). Drugs acting here include Succinylcholine or Hexamethonium, not Pirenzepine. * **Alpha & Beta:** These are adrenergic receptors that respond to adrenaline and noradrenaline. Drugs acting here (e.g., Prazosin or Propranolol) affect the sympathetic nervous system, not the parasympathetic system where Pirenzepine acts. **High-Yield Clinical Pearls for NEET-PG:** * **Selectivity:** While Pirenzepine is M1-selective, **Telenzepine** is another more potent M1 blocker. * **Clinical Use:** Its use has largely been superseded by Proton Pump Inhibitors (PPIs) and H2 blockers due to better efficacy and fewer side effects. * **M3 Antagonists:** For exams, remember **Darifenacin and Solifenacin** are selective M3 blockers used for overactive bladder (OAB). * **M2 Antagonists:** **Methoctramine** is a selective M2 blocker (primarily experimental). * **Rule of Odds:** M1, M3, and M5 are excitatory (Gq), while M2 and M4 are inhibitory (Gi).
Explanation: **Explanation:** The question asks for the statement that is **NOT** true. However, based on pharmacological principles, **Option A is actually a true statement**, making the question likely flawed or intended to identify a false statement among others. In standard pharmacology, Alpha-1 receptors are indeed primarily located on the **postsynaptic** effector membrane. **1. Analysis of Options:** * **Option A (Alpha-1 receptors are postsynaptic):** This is **TRUE**. Alpha-1 receptors are Gq-protein coupled receptors located postsynaptically on vascular smooth muscle, radial muscle of the iris, and sphincters. Their stimulation leads to IP3/DAG production and contraction. * **Option B (Beta-1 in the heart):** This is **TRUE**. Beta-1 receptors are predominantly located in the myocardium and SA node. Stimulation increases heart rate (chronotropy) and force of contraction (inotropy). * **Option C (Noradrenaline stimulates Beta-1):** This is **TRUE**. Noradrenaline is a potent agonist at Alpha-1, Alpha-2, and Beta-1 receptors. Notably, it has **negligible action on Beta-2 receptors**. * **Option D (Alpha-2 inhibits transmitter release):** This is **TRUE**. Alpha-2 receptors are primarily **presynaptic autoreceptors**. Their stimulation provides negative feedback, inhibiting further release of Norepinephrine. **2. NEET-PG High-Yield Pearls:** * **Receptor Coupling:** Remember **QISS** (Alpha-1: Gq; Alpha-2: Gi; Beta-1: Gs; Beta-2: Gs). * **Noradrenaline vs. Adrenaline:** Noradrenaline lacks Beta-2 activity (no vasodilation), whereas Adrenaline acts on all Alpha and Beta receptors. * **Exceptions:** While Alpha-2 is usually presynaptic, it is found postsynaptically in the CNS and on pancreatic beta cells (inhibiting insulin). Alpha-1 is almost exclusively postsynaptic. *Note: If this question appeared in an exam, it might be a "recall error" in the question stem or options, as all four statements are technically correct in standard textbooks.*
Explanation: **Latanoprost** is the correct answer. It is a **Prostaglandin F2α (PGF2α) analog**, which is currently the first-line treatment for Open-Angle Glaucoma. **Mechanism of Side Effect:**Latanoprost causes **heterochromia iridis** (specifically, increased brown pigmentation of the iris) by stimulating the proliferation and activity of melanocytes in the iris stroma [1]. This leads to increased melanin content. This change is often permanent. Other characteristic side effects of prostaglandin analogs include **hypertrichosis** (increased eyelash growth/thickness) and **periorbital fat atrophy).**Analysis of Incorrect Options:** * **A. Timolol:** A non-selective beta-blocker. It reduces aqueous humor production. Its primary side effects are local (stinging) and systemic (bradycardia, bronchospasm in asthmatics), but it does not affect iris color. * **C. Apraclonidine:** An alpha-2 agonist. It reduces aqueous production and increases uveoscleral outflow. Common side effects include lid retraction and local allergic reactions (blepharoconjunctivitis). * **D. Acetazolamide:** A carbonic anhydrase inhibitor. It reduces aqueous humor formation. Systemic side effects include paresthesia, metabolic acidosis, and hypokalemia. **High-Yield NEET-PG Pearls:** * **Mechanism of Action:** Prostaglandin analogs (Latanoprost, Bimatoprost, Travoprost) lower IOP by increasing **uveoscleral outflow**. * **Bimatoprost** is specifically FDA-approved for the treatment of eyelash hypotrichosis. * **Contraindication:** Prostaglandin analogs should be avoided in **uveitic glaucoma** as they may exacerbate intraocular inflammation (cystoid macular edema).
Explanation: **Explanation:** **1. Why the correct answer is right:** Myasthenia Gravis (MG) is an autoimmune disorder characterized by the production of antibodies against nicotinic acetylcholine receptors (Nm) at the neuromuscular junction (NMJ). This leads to a reduction in available receptors, causing muscle weakness. **Neostigmine** is a reversible anticholinesterase agent. Its primary mechanism of action is the **inhibition of the enzyme acetylcholinesterase (AChE)**. This enzyme is responsible for the degradation of acetylcholine (ACh) into choline and acetate. By inhibiting this enzyme, neostigmine prevents the breakdown of ACh, thereby increasing the concentration and prolonging the residence time of ACh at the synaptic cleft. This allows the available ACh to repeatedly stimulate the remaining functional receptors, improving neuromuscular transmission and muscle strength. **2. Why the incorrect options are wrong:** * **Option A:** Neostigmine does not stimulate the synthesis or release of "more" acetylcholine; it simply prevents the destruction of what is already released. * **Option C:** Neostigmine has no effect on the synthesis or density of acetylcholine receptors. The number of receptors remains reduced in MG; the drug simply optimizes the use of existing ones. * **Option D:** Increasing the action of cholinesterase would accelerate ACh breakdown, worsening the symptoms of Myasthenia Gravis. **3. NEET-PG High-Yield Pearls:** * **Neostigmine vs. Physostigmine:** Neostigmine is a quaternary ammonium compound (polar), so it **does not cross the Blood-Brain Barrier (BBB)**. Physostigmine is a tertiary amine and does cross the BBB. * **Edrophonium (Tensilon Test):** Historically used for diagnosis due to its ultra-short duration of action. * **Treatment Choice:** While Neostigmine is used, **Pyridostigmine** is often the preferred oral drug for maintenance therapy in MG due to its longer duration of action and fewer side effects. * **Direct Action:** Neostigmine also has a small, additional direct agonist effect on Nm receptors, which contributes to its efficacy in MG.
Explanation: **Explanation:** Cholinergic actions are mediated by the parasympathetic nervous system (PNS) through the neurotransmitter Acetylcholine (ACh) acting on Muscarinic (M) receptors. To remember these actions, use the mnemonic **DUMBBELLS** (Diarrhea, Urination, Miosis, Bradycardia, Bronchoconstriction, Emesis, Lacrimation, Lethargy, Salivation/Sweating). **Why Mydriasis is the Correct Answer:** **Mydriasis** refers to the dilation of the pupil, which is a **Sympathetic (Adrenergic)** action mediated by $\alpha_1$ receptors on the radial dilator pupillae muscle. In contrast, cholinergic stimulation causes **Miosis** (pupillary constriction) by acting on the $M_3$ receptors of the circular sphincter pupillae muscle. **Analysis of Incorrect Options:** * **Salivation:** Cholinergic stimulation of $M_3$ receptors in the salivary glands increases secretions. * **Sweating:** Although mediated by the sympathetic nervous system anatomically, the postganglionic fibers to eccrine sweat glands are **cholinergic** (releasing ACh onto $M_3$ receptors). Thus, sweating is a cholinergic effect. * **Bradycardia:** ACh acts on $M_2$ receptors in the SA node of the heart to decrease the heart rate (negative chronotropy). **High-Yield Clinical Pearls for NEET-PG:** 1. **Accommodation:** Cholinergic drugs cause contraction of the ciliary muscle ($M_3$), leading to "spasm of accommodation" and a decrease in intraocular pressure (useful in Glaucoma). 2. **Sweat Glands Exception:** Remember that sweat glands are the "exception to the rule"—they are sympathetic in origin but **cholinergic** in transmission. 3. **Atropine:** As a muscarinic antagonist, Atropine will cause the opposite effects: Mydriasis, dry mouth, and tachycardia.
Explanation: **Explanation:** In the management of anaphylactic shock, **Adrenaline (Epinephrine)** is the drug of choice because it acts as a physiological antagonist to the mediators of anaphylaxis (like histamine). Its therapeutic efficacy is derived from its action on **$\alpha_1$, $\beta_1$, and $\beta_2$ receptors**, while $\alpha_2$ stimulation plays no significant role in treating the acute crisis. * **Why $\alpha_2$ is the correct answer:** $\alpha_2$ receptors are primarily located presynaptically and function to inhibit the release of norepinephrine (negative feedback). Stimulation of $\alpha_2$ receptors does not contribute to the reversal of shock; in fact, it could theoretically decrease sympathetic outflow, which is counterproductive in a circulatory collapse. **Role of other receptors (Incorrect Options):** * **$\alpha_1$ (Option A):** Stimulation causes **vasoconstriction**, which increases peripheral vascular resistance and blood pressure, effectively reversing the hypotension and reducing mucosal edema (e.g., laryngeal edema). * **$\beta_1$ (Option C):** Stimulation increases **myocardial contractility (inotropy) and heart rate (chronotropy)**, improving cardiac output to combat shock. * **$\beta_2$ (Option D):** This is a life-saving action that causes **bronchodilation** to relieve bronchospasm and **stabilizes mast cells**, preventing further release of inflammatory mediators. **NEET-PG High-Yield Pearls:** * **Drug of Choice:** Adrenaline is the DOC for Anaphylactic Shock. * **Route of Administration:** **Intramuscular (IM)** in the anterolateral thigh (vastus lateralis) is preferred over SC or IV in the initial setting due to faster absorption and safety. * **Concentration:** 1:1000 (1 mg/ml) for IM; 1:10,000 (0.1 mg/ml) for IV. * **Standard Dose:** 0.5 mg IM for adults; 0.01 mg/kg for children.
Explanation: **Explanation:** Muscarinic antagonists (like Atropine) work by blocking M1, M2, and M3 receptors. To answer this question, one must understand the physiological role of the Parasympathetic Nervous System (PNS) and how blocking it alters organ function. **Why "Prolonged AV conduction" is the correct answer:** Parasympathetic stimulation (via the Vagus nerve acting on **M2 receptors**) normally slows the heart rate and **prolongs** AV conduction (increases the PR interval). Therefore, a muscarinic **antagonist** will block this inhibitory effect, leading to **shortened AV conduction** (increased conduction velocity) and tachycardia. It is used clinically to treat bradycardia and AV blocks. **Analysis of Incorrect Options:** * **A. Decreased gastric secretion:** M1 receptors on gastric parietal cells mediate acid secretion. Antagonists (e.g., Pirenzepine) block these, leading to reduced secretions. * **C. Decreased tracheobronchial secretion:** M3 receptors mediate glandular secretions. Antagonists significantly dry up secretions, which is why they are used as pre-anesthetic medications. * **D. Contraction of radial muscle of iris:** This is a **trick option**. Muscarinic antagonists cause **Mydriasis** (dilation). While they do this by paralyzing the sphincter pupillae (passive dilation), the sympathetic system's unopposed action on the **radial muscles** (alpha-1) remains. However, in many competitive exams, "Mydriasis" is the focus. *Note: If the question implies the direct action of the drug, antagonists cause relaxation of the circular muscle, not contraction of the radial muscle; however, B is the most definitively "opposite" physiological action.* **NEET-PG High-Yield Pearls:** * **Drug of choice (DOC)** for Organophosphate poisoning: **Atropine** (reverses muscarinic effects). * **Ipratropium/Tiotropium:** M3 antagonists used in COPD/Asthma because they cause bronchodilation and decrease secretions. * **Contraindication:** Avoid muscarinic antagonists in patients with **Angle-closure Glaucoma** (due to mydriasis) and **Benign Prostatic Hyperplasia (BPH)** (due to urinary retention).
Explanation: **Explanation:** The correct answer is **Noradrenaline (Norepinephrine)**. **1. Why Noradrenaline is Correct:** Noradrenaline is a potent agonist at **$\alpha_1$, $\alpha_2$, and $\beta_1$** receptors. Crucially, it has **negligible or no action on $\beta_2$ receptors**. Recent pharmacological studies also confirm its agonistic activity on **$\beta_3$** receptors (involved in thermogenesis and lipolysis). Because it lacks $\beta_2$ activity (which mediates vasodilation), Noradrenaline causes intense peripheral vasoconstriction, leading to a significant rise in both systolic and diastolic blood pressure. **2. Why the Other Options are Incorrect:** * **Phenylephrine (Option A):** This is a selective **$\alpha_1$ agonist**. It lacks significant action on $\beta$ receptors. * **Isoprenaline (Option B):** This is a non-selective **$\beta$ agonist** ($\beta_1$, $\beta_2$, and $\beta_3$). It has virtually no action on $\alpha$ receptors. * **Adrenaline (Option C):** Adrenaline is a potent agonist at **all** adrenoceptors: $\alpha_1$, $\alpha_2$, $\beta_1$, **and $\beta_2$**. The presence of $\beta_2$ activity distinguishes it from Noradrenaline and allows it to cause bronchodilation and vasodilation in skeletal muscle beds. **3. NEET-PG High-Yield Pearls:** * **Drug of Choice:** Noradrenaline is the first-line vasopressor for **Septic Shock**. * **Reflex Bradycardia:** Unlike Adrenaline, Noradrenaline often causes a "reflex bradycardia" because the intense $\alpha_1$-mediated vasoconstriction triggers the baroreceptor reflex, which overrides its direct $\beta_1$ stimulatory effect on the heart rate. * **Metabolism:** Both Adrenaline and Noradrenaline are metabolized by **COMT** and **MAO**; the end product measured in urine is **Vanillylmandellic acid (VMA)**. * **Rule of Thumb:** If a question mentions "no $\beta_2$ action" among catecholamines, always think of Noradrenaline.
Explanation: **Explanation:** Datura poisoning is characterized by **anticholinergic toxicity** (the "central anticholinergic syndrome"), caused by tropane alkaloids like scopolamine and hyoscyamine. These substances cross the blood-brain barrier (BBB), leading to both peripheral symptoms (tachycardia, dry mouth, dilated pupils) and central symptoms (delirium, hallucinations, seizures). **Why Physostigmine is the Correct Answer:** Physostigmine is a **tertiary amine** acetylcholinesterase inhibitor. Unlike other carbamates, its uncharged structure allows it to **cross the blood-brain barrier**. By inhibiting the breakdown of acetylcholine, it increases synaptic concentrations of the neurotransmitter, effectively reversing both the peripheral and, crucially, the **central neurotoxic effects** of Datura. **Analysis of Incorrect Options:** * **Neostigmine & Pyridostigmine:** These are **quaternary ammonium** compounds. They are polar/charged and **cannot cross the blood-brain barrier**. While they might reverse peripheral symptoms, they are ineffective against the life-threatening CNS manifestations of Datura poisoning. * **Atropine:** Atropine is a competitive muscarinic antagonist. Since Datura poisoning is already a state of atropine-like toxicity, administering more atropine would worsen the condition. (Note: Atropine is the antidote for organophosphate poisoning, not Datura). **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Datura/Atropine Toxicity:** "Mad as a hatter (delirium), Red as a beet (flushing), Dry as a bone (anhidrosis), Blind as a bat (mydriasis), and Hot as a hare (hyperthermia)." * **Physostigmine Precaution:** It should be administered via slow IV injection. Rapid administration can cause bradycardia or seizures. It is contraindicated in patients with TCA (Tricyclic Antidepressant) overdose due to increased cardiotoxicity. * **DOC:** Physostigmine is also the drug of choice for Belladonna poisoning.
Cholinergic Agonists
Practice Questions
Cholinergic Antagonists
Practice Questions
Adrenergic Agonists
Practice Questions
Adrenergic Antagonists
Practice Questions
Ganglionic Agents
Practice Questions
Neuromuscular Blocking Agents
Practice Questions
Autonomic Drugs in Ophthalmology
Practice Questions
Autonomic Drugs in Cardiovascular Disease
Practice Questions
Autonomic Drugs in Respiratory Disease
Practice Questions
Autonomic Drugs in Urological Disorders
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free